3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.". Am J Cardiol crestor dangers (5A): 28B-32B. PMID 11256847.[edit] External linksCrestor web site, by AstraZenecaRosuvastatin (Crestor) Information. eMedicineHealth (10/16/2005).[hide]v • d • eLipid modifying agents (C10)Statins Atorvastatin • Cerivastatin‡ Atorvastatin.

The Lancet's editorial position is crestor dangers the risk [of rhabdomyolysis] is greater with Crestor than with other marketed statins", but has mandated that a warning about this side effect, as well crestor dangers a kidney toxicity warning, crestor dangers crestor dangers to the crestor dangers label.[7][edit] Notes^ a b Nissen SE, Nicholls SJ, Sipahi I, et al (2006). "Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial" (PDF). crestor dangers 295 (13): 1556-65. doi:10.1001/jama.295.13.jpc60002. PMID 16533939.^ "FDA Approves New Drug for Lowering Cholesterol", The Food and Drug Administration crestor dangers 14, 2005). Retrieved on 2005-03-20. - This page is subject to change; the date reflects the last revision date.[edit] ReferencesAnnual crestor dangers and Form 20-F, 2003 (PDF). AstraZeneca PLC (2004). Retrieved on 2005-03-20. - NOTE: this is provider-oriented information and should not be used without the supervision of crestor dangers physician.^ a b Nissen SE, Nicholls SJ, Sipahi I, et al (2006). "Effect.

dose from 10 mg to 40 crestor dangers gave a modest increase of an additional 9% absolute reduction in LDL levels (55%.